|Tested species reactivity||Virus|
|Published species reactivity||Virus, Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Recombinant fusion protein of bacterial beta-galactosidase and EBV LMP-1|
|Storage buffer||tissue culture supernatant|
|Contains||15mM sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||1:100-1:200|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:200|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 3 publications below|
This product requires protein digestion pre-treatment of paraffin sections using trypsin or pronase.
Prior to reconstitution, store at 4°C. Reconstitute with 1 ml of distilled water. After reconstitution, store undiluted at -20°C, avoiding freeze/thaw cycles.
The Epstein-Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is a cancer-causing virus of the herpes family, which includes herpes simplex virus 1 and 2, and is one of the most common viruses in humans. Epstein-Barr virus occurs worldwide and causes infectious mononucleosis (glandular fever). There is also strong evidence that the virus has a primary role in the pathogenesis of multiple autoimmune diseases, particularly dermatomyositis, systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, and multiple sclerosis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.
MA1-80022 was used in immunohistochemistry to study patient response to adoptive immunotherapy
|Li J,Chen QY,Mo H,Zhang YL,Huang ZF,Zeng YX||International journal of biological sciences (7:607)||2011|
Nasopharyngeal extranodal NK/T-cell lymphoma, nasal type: retrospective study of 18 consecutive cases in Guangzhou, China.
MA1-80022 was used in immunohistochemistry to report on 18 cases of nasopharyngeal extranodal NK/T-cell lymphoma, nasal type
|Huang YH,Wu QL,Zong YS,Feng YF,Hou JH||International journal of surgical pathology (19:51)||2011|
Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
MA1-80022 was used in immunohistochemistry to study the changes in germinal center after the Epstein-Barr virus infection
|Kurth J,Hansmann ML,Rajewsky K,Küppers R||Proceedings of the National Academy of Sciences of the United States of America (100:4730)||2003|